Verily Life Sciences
Teresa Mallen is an experienced finance professional currently serving as the Head of Commercial Finance at Verily Life Sciences since June 2021. Prior to this role, Teresa held the position of Senior Finance Director for Commercial and R&D Finance at Fluidigm Corporation from September 2018 to June 2021. Additionally, Teresa worked as the Senior Global Commercial Finance Manager at Thermo Fisher Scientific, where responsibilities included managing a $2B global commercial annual operating and sales plan for the Genetic Analysis Division. Teresa's earlier experience includes serving as Finance Controller at Agilent Technologies, overseeing a $1B Diagnostics & Genomics portfolio, as well as a Senior FP&A Finance role managing the Life Sciences Group FP&A for various sectors. Teresa holds an MBA and a Bachelor's degree in Accounting from San Jose State University.
Verily Life Sciences
45 followers
Verily's mission is to make the world’s health data useful so that people enjoy longer and healthier lives. The company was launched in 2015 and is a subsidiary of Alphabet.